Prospective,randomized clinical trial for homeostasis via hemospray after endoscopic resection in the upper gastrointestinal tract

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00007951

Enrollment

Registered

2015-07-02

Start date

2015-07-05

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemostasis after endoscopic resection of polyps in the stomach and duodenum hemostasis C26.9

Interventions

Group 1: Patients after endoscopic resection with bleeding is Hemospray applied for hemostasis Group 2: conventional hemostasis

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Patients older than 18 years - Patients with a lesion in the upper gastrointestinal tract and medical indication for resection . - Bleeding complications ( bleeding Sure , spurting bleeding or bleeding with visible vessel )

Exclusion criteria

Exclusion criteria: - Lack of consent - Pregnancy - Coagulation disorders ( Quick 50s , platelets < 100,000 / nl ) - Taking antiplatelet < 7 days. - Taking an oral anticoagulation

Design outcomes

Primary

Measure	Time frame
The main objective of the study is to investigate whether an application of Hemospray © bleeding complication after endoscopic resection may reduce upper GI. Hemospray © Company Cook is already used in the therapy of acute bleeding complications of the upper and lower gastrointestinal tract. The question is whether the high rate is influenced to bleeding complications and postintervention bleeding. In steady course all occurring complications can be detected accurately, distinguishing between complications within the first 24 hours after surgery and complications occurring later. , In addition, a re-EGD is in each patient the day after the intervention performed in order to assess the wound surface, possibly to detect emerging local bleeding and endoscopically to breastfeed and possibly to treat small residual Adenomreste after. Again, any findings and any re-intervention in the frame of the documents.	—

Measure

Time frame

The main objective of the study is to investigate whether an application of Hemospray © bleeding complication after endoscopic resection may reduce upper GI. Hemospray © Company Cook is already used in the therapy of acute bleeding complications of the upper and lower gastrointestinal tract. The question is whether the high rate is influenced to bleeding complications and postintervention bleeding. In steady course all occurring complications can be detected accurately, distinguishing between complications within the first 24 hours after surgery and complications occurring later. , In addition, a re-EGD is in each patient the day after the intervention performed in order to assess the wound surface, possibly to detect emerging local bleeding and endoscopically to breastfeed and possibly to treat small residual Adenomreste after. Again, any findings and any re-intervention in the frame of the documents.

—

Countries

Germany

Contacts

Public ContactAndrea May

Sana Klinikum Offenbach

Andrea.May@Sana.de06984053971

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026